Radioiodine therapy is the gold-standard curative treatment for feline hyperthyroidism, but the isolation protocol required for radiation safety creates significant short-term welfare challenges for affected cats.
The isolation period following radioiodine therapy presents a genuine welfare dilemma: cats are confined alone without normal human contact while experiencing the physiological effects of treatment. Facilities vary widely in enrichment provision during this period. Owners who choose daily medication or surgery instead may avoid isolation stress but face long-term compliance challenges. The cure represents a major welfare improvement over chronic disease.